Radioactive iodine treatment for persistent thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests if a standard radioactive iodine treatment can help people with a type of thyroid cancer (called differentiated thyroid cancer) who have signs of the disease returning after their first treatment. It aims to see if this treatment can control the cancer and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of thyroid cancer called differentiated thyroid cancer.
- You have had your thyroid gland removed (total thyroidectomy) and received radioactive iodine therapy before.
- Your cancer has shown signs of coming back or persisting (based on blood tests) during follow-up, but no visible tumors on imaging.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain cancer “targeted therapy” medicines can make radioactive iodine (RAI) therapy work better for thyroid cancer that has spread to the lungs. It also involves taking special whole-body scans to measure how much radioactive iodine gets taken up by the cancer.
This study compares two ways of replacing thyroid hormone after radioactive iodine therapy for high-risk thyroid cancer. It aims to find which approach is more effective and better for patients.
This study looks at how much iodine your body absorbs after you follow a low-iodine diet before radioactive iodine treatment (131I) for thyroid cancer. It may help improve how safely and effectively this treatment is planned.
This trial studies how well radioactive iodine treatment works for people with certain types of thyroid cancer that have a low or intermediate risk of coming back. It aims to see if this treatment is effective and safe for these patients.
This Phase 1 study tests how doctors plan a combination of two radiation approaches—external beam radiation and radioactive iodine—for thyroid cancer that is not fully responding to standard treatment. It may help people who still have iodine-avid tumor spots, but whose iodine uptake looks too low to work well with radioactive iodine alone.
This study looks at how different doses of radioactive iodine affect people with thyroid cancer after they have had their thyroid removed. It may help doctors choose the best dose for future patients.
Hear when a new Differentiated Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.